Press Release June 20, 2023 Over-the-Top Media Service (OTT Service) Market Surges with Strong Momentum, Projected to Exceed US$ 219,960 Million, Sustaining a Robust 10.0% CAGR from 2023 to 2029
Press Release June 20, 2023 NF-kappa B Inhibitors Pipeline and Clinical Trials Assessment 2023: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Complexa, Accendatech, Serenex, OncoViRx, Novo Nordisk
Press Release June 20, 2023 Geographic Atrophy Pipeline Drugs Analysis Report, 2023: FDA Approvals, Clinical Trials, Therapies, by DelveInsight | Ionis Pharmaceuticals, Apellis, Annexon Inc., Genentech, Alexion, AstraZeneca
Press Release June 20, 2023 Dengue Pipeline Drugs Analysis Report (2023 Updates): FDA Approvals, Clinical Trials, Therapies, by DelveInsight | Abivax, Plex Pharmaceuticals, Codagenix, Emergex Vaccines, Visterra, Merck Sharp
Press Release June 20, 2023 Post-operative Cataract Surgery Inflammation Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight | Mallinckrodt Pharma, Salix Pharma, GlaxoSmithKline
Press Release June 20, 2023 Instaoffyz Launches New Yoga and Meditation Video App, YogaSiddhi, for Users and Yoga Trainers
Press Release June 20, 2023 Vernal Keratoconjunctivitis Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Santen, Novartis, Senju Pharma, Allakos, Astellas, Akari Therapeutics
Press Release June 20, 2023 Type 1 Diabetes Pipeline Assessment, 2023 Updates | In-depth Insights into the Emerging Drugs, Latest Drug Approvals, Clinical Trials, and Treatment Outlook | Novartis, Histogen, Vertex Pharma
Press Release June 20, 2023 Blepharitis Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | Allergan Plc, Bausch Health , Novartis, Pfizer, AxeroVision
Press Release June 20, 2023 Lung Transplant Rejection Pipeline Report, 2023 Updates: In-depth Analysis into the Clinical Trials, Latest Drug Approvals, Emerging Drugs, and Growth Prospects | Kamada, Genentech, Bristol Myers